The desk's No. 121 · 73/100
NovoCare Pharmacy
Novo Nordisk's first-party direct-to-consumer pharmacy for branded Wegovy (semaglutide).
- Semaglutide
- From $349/mo (2.4 mg dose, brand-name)
- Tirzepatide
- Not disclosed
Briefs · page 4 of 14
Each GLP-1 telehealth provider we track, graded on the Brief Score — price stability, supply reliability, transparency and access.
Showing 121–160 of 546. Most recent verification in the ranking: .
Tracked and scored — read the caveats.
Brief Scores are our editorial judgment per the methodology; facts reflect each provider's public disclosures at last check. A commission never changes a score, and it never softens what we write about a provider. What it does move is position: this index runs in ranking order, and providers we have a commercial relationship with sit ahead of providers we do not. Weigh the write-up, not the slot — see our disclosure. Not medical advice.
The desk's No. 121 · 73/100
NovoCare Pharmacy
Novo Nordisk's first-party direct-to-consumer pharmacy for branded Wegovy (semaglutide).
Shopping on price?
See every provider with its price direction and the note behind it.
Open the ranking →